the United States, researchers held on Thursday of the 4th vaccine research annual meeting reports, some reduce heart risk factors of the vaccine are being developed and used in heart disease is likely to prevent. Walter Reed Army institute's Carl r. Alving doctor points out, a variety of infection factors and artery & hellip; & hellip; The United States, researchers held on Thursday of the 4th vaccine research annual meeting reports, some reduce heart risk factors of the vaccine are being developed and used in heart disease is likely to prevent.
Walter Reed Army institute's Carl r. Alving doctor points out, a variety of infection factors and atherosclerosis or hardening of the arteries, and he related disease introduced some can reduce heart disease risk factors such as high cholesterol vaccine development.
currently has found the fatty plaques clogged arteries are carrying some bacteria, such as chlamydia, cytomegalovirus, h. pylori. Study found that injecting animals chlamydia will increase atherosclerosis tesult; With antibiotics decreases the number of atherosclerotic formation; The use of vaccines against chlamydia will get the same effect.
Alving doctor pointed out that if the vaccine can reduce the number of atherosclerosis, so no matter from business, or public health point of view, the value of chlamydial vaccines are huge.
which researchers are lots of studies to determine whether chlamydia vaccine can reduce human cardiovascular disease incidence.
recently, AVANT immunotherapy company has completed the cholesterol ester transporters (CETP) preliminary test of vaccine. CETP can will high-density lipoprotein (HDL) cholesterol transship to low-density lipoprotein (LDL), the vaccine by blocking the enzyme to achieve higher LDL levels of HDL levels and reduce the role.
Alving doctor thinks, developed reduce artery atherosclerosis risk factors (infection and metabolic) of the vaccine is expected to succeed.
